Open access
Open access
Powered by Google Translator Translator

Mon April 27 – 10 Stories of The Day!

26 Apr, 2020 | 21:42h | UTC

 

1 – “Immunity passports” in the context of COVID-19 – World Health Organization

Commentaries: WHO: ‘No Evidence’ That COVID-19 Antibodies Protect From Potential Re-infection – TIME AND WHO warns against coronavirus immunity passports – The Guardian AND ‘No Evidence’ Yet That Recovered COVID-19 Patients Are Immune, WHO Says – NPR AND “No evidence” that recovered COVID-19 patients cannot be reinfected: WHO – Reuters

 

2 – A real-time dashboard of clinical trials for COVID-19 – The Lancet

See the platform: COVID-19 clinical trials registry

 

3 – Management of COVID-19 Respiratory Distress – JAMA

Related Podcast: Coronavirus (COVID-19) Update: Ventilatory Management for COVID-Related Respiratory Failure – JAMA

 

4 – Mild or Moderate Covid-19 – New England Journal of Medicine

 

5 – Transforming ORs into ICUs – New England Journal of Medicine

 

6 – Asymptomatic Transmission, the Achilles’ Heel of Current Strategies to Control Covid-19 – New England Journal of Medicine

 

7 – Presymptomatic SARS-CoV-2 Infections and Transmission in a Skilled Nursing Facility – New England Journal of Medicine

Commentary: Expert reaction to study looking at presymptomatic SARS-CoV-2 coronavirus transmission in a nursing home in the US – Science Media Centre

 

8 – When Should Schools Reopen? – Center for Global Development

 

9 – Universal Do-Not-Resuscitate Orders, Social Worth, and Life-Years: Opposing Discriminatory Approaches to the Allocation of Resources During the COVID-19 Pandemic and Other Health System Catastrophes – Annals of Internal Medicine

Related Debate: Is it Wrong to Prioritize Younger Patients with Covid-19?

 

10 – Coronavirus Disease (COVID-19) Updates / 27 April 2020 Edition

27 April 2020 Edition – COVID-19/SARS-CoV-2 Latest Articles, Guidelines, News & Perspectives (several free resources)

 


Stay Updated in Your Specialty

Telegram Channels
Free

WhatsApp alerts 10-day free trial

No spam, just news.